In dissecting the role of the JAK/STAT pathway in ALK+ ALCL, a controversy has emerged as to whether NPM-ALK can bypass JAK to phosphorylate STAT3 directly. This evidence concerns the gene ALK and anaplastic large cell lymphoma.